| Fiscal Year End | Company Status | Exempt Flag |
| December 31 | Suspend | N |
|
|
|
|
|
| Incorporation Locations |
| Inc. Date | Expiry Date | Country | Region | Description |
| 3/Jan/2013 | | Canada | British Columbia | |
|
|
| Exchange Filing Office |
| Location |
| Vancouver Regional Service Office |
|
|  |
| Business Type(s) |
| Primary/Secondary | Business Type | Details |
| Primary
| Biotechnology Research &/or Development
| News Release March 12, 2015-Aequus Pharmaceuticals Inc. is a Vancouver-based specialty pharmaceutical company focused on enhancing delivery methods for approved drugs and select consumer products that are limited by non-compliance, high frequency dosing, first-pass metabolism side-effects, painful injections, or where the therapeutic profile can be improved by making a long-acting alternative available.
|
|
|
| Securities |
| Symbol | Security Name | Market | Status |
| AQS | Aequus Pharmaceuticals Inc. | TSX Venture | SUSPEND |
|
|
| Name History | From | To |
| Aequus Pharmaceuticals Inc. | 29/Dec/2014 | Present |
|
|
| Company Facts Reconciliation |
| Subject | Date Returned |
| Spring 2015 CFR | Not Received |
|
|
|
|
|
